Media coverage about NanoString Technologies (NASDAQ:NSTG) has been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. NanoString Technologies earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave media coverage about the biotechnology company an impact score of 45.9098178871775 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
NanoString Technologies (NSTG) traded up 4.98% during trading on Tuesday, reaching $16.43. 719,713 shares of the company’s stock were exchanged. NanoString Technologies has a 52 week low of $13.17 and a 52 week high of $23.45. The stock has a 50-day moving average of $14.91 and a 200-day moving average of $17.07. The stock’s market capitalization is $414.10 million.
NanoString Technologies (NASDAQ:NSTG) last posted its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.20) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.37) by $0.17. The business had revenue of $34.59 million during the quarter, compared to the consensus estimate of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. On average, equities research analysts anticipate that NanoString Technologies will post ($2.12) EPS for the current year.
A number of analysts recently commented on NSTG shares. ValuEngine upgraded shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Zacks Investment Research upgraded shares of NanoString Technologies from a “hold” rating to a “buy” rating and set a $19.00 target price for the company in a research note on Wednesday, July 5th. Cowen and Company reiterated a “buy” rating on shares of NanoString Technologies in a research note on Friday, July 14th. Finally, BidaskClub cut shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $18.50.
TRADEMARK VIOLATION WARNING: “NanoString Technologies (NSTG) Earns News Sentiment Score of 0.10” was originally posted by Stock Observer and is owned by of Stock Observer. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.thestockobserver.com/2017/09/12/nanostring-technologies-nstg-earns-news-sentiment-score-of-0-10.html.
About NanoString Technologies
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.